Vaxart, Inc.（VXRT）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 Vaxart, Inc.（VXRT）报告了 46 笔 Form 4 交易（最近一笔 2026-07-20）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-20 | Finney Kevin | 董事 | 买入 | 39,400 | $0 |
| 2026-07-17 | HERON ELAINE J | 董事 | 买入 | 39,400 | $0 |
| 2026-07-17 | BREITMEYER JAMES B | 董事 | 买入 | 8,315 | $0 |
| 2026-07-17 | Watson W. Mark | 董事 | 买入 | 39,400 | $0 |
| 2026-07-17 | Wheadon David E. | 董事 | 买入 | 39,400 | $0 |
| 2026-05-26 | Watson W. Mark | 董事 | 买入 | 10,000 | $6,500 |
| 2026-05-21 | Grasman Jeroen Nicolaas | Chief Financial Officer | 卖出 | 31,395 | $19,151 |
| 2026-05-01 | BREITMEYER JAMES B | 董事 | 买入 | 78,800 | $0 |
| 2026-03-31 | Tucker Sean | SVP, Chief Scientific Officer | 卖出 | 3,924 | $2,551 |
| 2026-03-31 | Cummings James F. | Chief Medical Officer | 卖出 | 3,292 | $2,140 |
| 2026-03-26 | Tucker Sean | SVP, Chief Scientific Officer | 卖出 | 36,418 | $25,128 |
| 2026-03-26 | Lo Steven | President, Chief Exec Officer | 卖出 | 126,028 | $86,959 |
| 2026-03-26 | Berg Edward B | SVP, General Counsel | 卖出 | 36,418 | $25,128 |
| 2026-03-26 | Cummings James F. | Chief Medical Officer | 卖出 | 30,551 | $21,080 |
| 2026-03-20 | Berg Edward B | SVP, General Counsel | 卖出 | 8,072 | $5,085 |
| 2026-03-20 | Lo Steven | President, Chief Exec Officer | 卖出 | 22,425 | $14,128 |
| 2026-03-20 | Tucker Sean | SVP, Chief Scientific Officer | 卖出 | 8,072 | $5,085 |
| 2026-03-20 | Cummings James F. | Chief Medical Officer | 卖出 | 6,772 | $4,266 |
| 2026-03-18 | Berg Edward B | SVP, General Counsel | 买入 | 115,000 | $0 |
| 2026-03-18 | Lo Steven | President, Chief Exec Officer | 买入 | 846,500 | $0 |
| 2026-03-18 | Tucker Sean | SVP, Chief Scientific Officer | 买入 | 200,000 | $0 |
| 2026-03-18 | Grasman Jeroen Nicolaas | Chief Financial Officer | 买入 | 227,000 | $0 |
| 2026-03-18 | Cummings James F. | Chief Medical Officer | 买入 | 227,000 | $0 |
| 2026-02-05 | Berg Edward B | SVP, General Counsel | 卖出 | 9,265 | $5,652 |
| 2026-02-05 | Tucker Sean | SVP, Chief Scientific Officer | 卖出 | 9,265 | $5,652 |
来源：SEC Form 4 申报文件 · 截至 2026-07-20